Residual and Recurrent Gastrointestinal Stromal Tumors With KIT Mutations: Findings at First Follow-Up CT After Imatinib Treatment

被引：3
|
作者：
Choi, Dongil [1 ,2 ]
Yoo, Eun Young [1 ,2 ]
Kim, Kyoung-Mee [3 ]
Sohn, Tae Sung [4 ]
Lee, Won Jae [1 ,2 ]
Lee, Ji Young [1 ,2 ]
Chang, Ilsoo [1 ,2 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Dept Radiol, Kangnam Ku, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Kangnam Ku, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Surg, Samsung Med Ctr, Seoul, South Korea
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2009年 / 193卷 / 02期
关键词：
cystic change; follow-up CT; gastrointestinal stromal tumor; GIST; imatinib treatment; KIT mutation; POSITRON-EMISSION-TOMOGRAPHY; TYROSINE KINASE; POOR-PROGNOSIS; CYSTIC CHANGES; MESYLATE; INHIBITION; METASTASES; RESISTANCE; DELETIONS; BIOLOGY;
D O I：
10.2214/AJR.08.2106
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The purpose of this study was to correlate findings on the first follow-up CT after treatment with imatinib in patients with residual or recurrent gastrointestinal stromal tumors (GISTs) with the different types of KIT mutation present at initial resection. CONCLUSION. Residual and recurrent GISTs with KIT mutation of exon 11 deletion more frequently showed both tumor shrinkage and cystic change on 2-month follow-up CT images after the start of imatinib treatment than did other mutation types.
引用
收藏
页码：W100 / W105
页数：6
相关论文
共 50 条
  • [21] Gastrointestinal stromal tumors: Epidemiology, diagnostics, therapy and follow-up
    Schöffel N.
    Brüggmann D.
    Bendels M.H.K.
    Groneberg D.A.
    Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2016, 66 (2) : 98 - 100
  • [22] Imatinib mesylate treatment in a dog with gastrointestinal stromal tumors with a c-kit mutation
    Irie, Mitsuhiro
    Takeuchi, Yoshinori
    Ohtakei, Yuzo
    Suzukii, Hitomi
    Nagata, Nao
    Miyoshi, Takuma
    Kagawa, Yumiko
    Yamagami, Tetsushi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2015, 77 (11): : 1535 - 1539
  • [23] Staging and follow-up of gastrointestinal tumors with PET/CT
    S. J. Rosenbaum
    H. Stergar
    G. Antoch
    P. Veit
    A. Bockisch
    H. Kühl
    Abdominal Imaging, 2006, 31 : 25 - 35
  • [24] Staging and follow-up of gastrointestinal tumors with PET/CT
    Rosenbaum, SJ
    Stergar, H
    Antoch, G
    Veit, P
    Bockisch, A
    Kühl, H
    ABDOMINAL IMAGING, 2006, 31 (01): : 25 - 35
  • [25] Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Blay, Jean-Yves
    Blomqvist, Carl
    Bonvalot, Sylvie
    Boukovinas, Ioannis
    Casali, Paolo G.
    De Alava, Enrique
    Dei Tos, Angelo Paolo
    Dirksen, Uta
    Duffaud, Florence
    Eriksson, Mikael
    Fedenko, Alexander
    Ferrari, Andrea
    Ferrari, Stefano
    Garcia del Muro, Xavier
    Gelderblom, Hans
    Grimer, Robert
    Gronchi, Alessandro
    Hall, Kirsten Sundby
    Hassan, Bass
    Hogendoorn, Pancras
    Hohenberger, Peter
    Issels, Rolf
    Joensuu, Heikki
    Jost, Lorenz
    Jurgens, Heribert
    Kager, Leo
    Le Cesne, Axel
    Leyvraz, Serge
    Martin, Javier
    Merimsky, Ofer
    Nishida, Ofer
    Picci, Piero
    Reichardt, Peter
    Rutkowski, Piotr
    Schlemmer, Marcus
    Sleijfer, Stefan
    Stacchiotti, Silvia
    Taminiau, Antoine
    Wardelmann, Eva
    ANNALS OF ONCOLOGY, 2012, 23 : 49 - 55
  • [26] Fourteen-year follow-up results of imatinib therapy in patients with unresectable and metastatic gastrointestinal stromal tumors
    Kanda, Tatsuo
    Ichikawa, Hiroshi
    Ishikawa, Takashi
    Muneoka, Yusuke
    Kano, Yosuke
    Naito, Tetsuya
    Suzuki, Satoshi
    Wakai, Toshifumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (12) : 1870 - 1877
  • [27] A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome
    Zhu, Jiang
    Yang, Yu
    Zhou, Lin
    Jiang, Ming
    Hou, Mei
    BMC CANCER, 2010, 10
  • [28] A long-term follow-up of the imatinib mesylate treatment for the patients with recurrent gastrointestinal stromal tumor (GIST): the liver metastasis and the outcome
    Jiang Zhu
    Yu Yang
    Lin Zhou
    Ming Jiang
    Mei Hou
    BMC Cancer, 10
  • [29] CT and MRI findings in KIT-weak or KIT-negative atypical gastrointestinal stromal tumors
    Ukihide Tateishi
    Mototaka Miyake
    Tetsuo Maeda
    Yasuaki Arai
    Kunihiko Seki
    Tadashi Hasegawa
    European Radiology, 2006, 16 : 1537 - 1543
  • [30] Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months
    Lei, Cheng
    Zhao, Bing
    Wang, Qisan
    Ge, Lei
    Wang, Haijiang
    JOURNAL OF BUON, 2018, 23 (02): : 460 - 467
12345